For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Take a look at our BETA site and see what we’ve done so far.
Search and browse selected products
Purchase these through your usual distributor
Epigenetics alterations occur in many human diseases, including cancer. Investigating epigenetic modifications in disease settings offers us valuable insights into underlying signaling pathways and disease progression, eventually contributing to the development of targeted therapies.
See how we can help you study epigenetics in the context of cancer and other diseases. Take a look at our latest webinars, guides, and posters covering such topics as cancer epigenetics, histone mutations, epigenetics in drug development and diagnostics, and many others.
To support ongoing drug discovery efforts, we provide an extensive portfolio of proteomic tools, from recombinant antibodies and proteins to ELISA kits and cell lines, to key targets in cancer epigenetics disease areas, including acute myeloid leukemia (AML), colorectal, prostate and breast cancers, glioma, melanoma and lung cancer (NSCLC).
Explore our highlighted epigenetics products to support drug discovery in AML, melanoma, and NSCLC:
SimpleStep ELISA® kits
Achieve fast and reliable results with highly sensitive 90-minutes ELISAs with only a one-wash step protocol
Resolve reproducibility issues using recombinant antibodies with superior batch-to-batch consistency and long-term security of supply
Knock-out cell lines
Save time and streamline your discovery workflow with reliable, well-characterized gene-edited cell lines.
Understand the role of key epigenetic targets and pathways in cancer with our in-depth guide covering histones, DNA and RNA modifications, and Polycomb and chromatin remodeling.
Unravel complex epigenetic mechanisms implicated in AML with our interactive pathway poster, highlighting key targets in this field and our products against these targets.
Explore key epigentics targets involved in the regulation of the biological processes critical to cancer with our interactive poster.
Hear A. Ganesan, Mark Eccleston, and Neil Michaud present their latest research on epigenetics in drug development and diagnostics
Understand the role of H3K27M, H3K36M, and other histone mutations in cancer and accelerate your research with our recombinant monoclonal antibodies to key histone mutants.
Hear from Richard Centore on the discovery of novel BAF inhibitors for cancer treatment and from Sydney Fobare on EZH2 inhibition in AML.